Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operation
- 1 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Pediatrics
- Vol. 16 (5), 528-532
- https://doi.org/10.1007/s12519-020-00350-8
Abstract
Background Increased meningitis caused by extensively drug-resistant bacillary presents a significant challenge in antibiotic selection. The aim of our study was to evaluate the efficacy and safety of polymyxin in the treatment of post-neurosurgical meningitis due to the extensively drug-resistant bacillary in children. Methods We performed a retrospective study on post-neurosurgical meningitis caused by the extensively drug-resistant bacillary in children, who were treated with polymyxin for >= 3 days. Results Among five post-neurosurgical meningitis cases that were included, the children were infected by Acinetobacter baumannii (n = 3), Klebsiella pneumonia (n = 1), and Pseudomonas aeruginosa (n = 1). The drug susceptibility test showed that they were extensively drug-resistant bacillary. Two patients received intravenous polymyxin E. Three children received intravenous combined with intraventricular injection of polymyxin B. One patient infected by Klebsiella pneumonia eventually died of septic shock. No serious adverse effects of polymyxin were observed. Conclusions Polymyxin is a safe and effective therapy for post-neurosurgical, multidrug-resistant bacillary meningitis in children.Funding Information
- Department of Education of Zhejiang Province (Y201737787)
- National Natural Science Foundation of China (81901989)
- China Postdoctoral Science Foundation (2019M652108)
This publication has 15 references indexed in Scilit:
- Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysisThe Brazilian Journal of Infectious Diseases, 2015
- Risk factors for nephrotoxicity onset associated with polymyxin B therapyJournal of Antimicrobial Chemotherapy, 2015
- Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcomeJournal of Medical Microbiology, 2014
- Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: A hospital-based retrospective studyJournal of Microbiology, Immunology and Infection, 2014
- Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic reviewClinical Microbiology & Infection, 2010
- Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2010
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic StewardshipClinical Infectious Diseases, 2009
- Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg doseJournal of Antimicrobial Chemotherapy, 2006
- Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomesJournal of Clinical Neuroscience, 2005
- Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistinJournal of Infection, 2005